Cargando…

IPO7 promotes pancreatic cancer progression via regulating ERBB pathway

BACKGROUND: Importin 7 (IPO7) belongs to the Importin β family and is implicated in the progression of diverse human malignancies. This work is performed to probe the role of IPO7 in pancreatic cancer development and its potential downstream mechanisms. METHODS: IPO7 expression in PC and paracancero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ming, Xu, Dongqiang, Zhan, Yijun, Tan, Shiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119836/ https://www.ncbi.nlm.nih.gov/pubmed/35588577 http://dx.doi.org/10.1016/j.clinsp.2022.100044

Ejemplares similares

High-profit IPO strategies: finding breakout IPOs for investors and traders
por: Taulli, Tom, et al.
Publicado: (2013)

Pancreatic Cancer Progression Is Regulated by IPO7/p53/LncRNA MALAT1/MiR-129-5p Positive Feedback Loop
por: Xu, Jin, et al.
Publicado: (2021)

Corporate governance in IPO firms
por: Lehmann, Erik E, et al.
Publicado: (2020)

Regulation A+ and Other Alternatives to a Traditional IPO
por: Feldman, David
Publicado: (2018)

IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS-ERK Pathway
por: Li, Meiyu, et al.
Publicado: (2022)

Latent class analysis of IPOs in the Nordics
por: Bask, Mikael, et al.
Publicado: (2021)

Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene Product
por: Yang, Ya-Chun, et al.
Publicado: (2021)

Correction: Latent class analysis of IPOs in the Nordics
Publicado: (2023)

IPO: a tool for automated optimization of XCMS parameters
por: Libiseller, Gunnar, et al.
Publicado: (2015)

Unicorns’ growth and financial flexibility before and after the IPO
por: Zhou, Man, et al.
Publicado: (2023)

ERBB4 promotes the progression of inflammatory breast cancer through regulating PDGFRA
por: Gong, Ni, et al.
Publicado: (2020)

GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway
por: Zhang, Xiao-Xin, et al.
Publicado: (2019)

COVID-19: Fear of pandemic and short-term IPO performance
por: Mazumder, Sharif, et al.
Publicado: (2021)

Nuclear Transporter IPO13 Is Central to Efficient Neuronal Differentiation
por: Gajewska, Katarzyna A., et al.
Publicado: (2022)

Competitive threat and strategic disclosure during the IPO quiet period
por: Qiu, Yetaotao, et al.
Publicado: (2022)

Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription
por: Huang, Xince, et al.
Publicado: (2019)

Mutation of IPO13 causes recessive ocular coloboma, microphthalmia, and cataract
por: Huang, Xiu-Feng, et al.
Publicado: (2018)

DMBA promotes ErbB2-mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability
por: Ma, Zhikun, et al.
Publicado: (2018)

IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation
por: Zhang, Wenjuan, et al.
Publicado: (2019)

IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells
por: Nachmias, Boaz, et al.
Publicado: (2022)

YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression
por: He, Chunbo, et al.
Publicado: (2015)

Comparable Stocks, Boundedly Rational Stock Markets and IPO Entry Rates
por: Chok, Jay, et al.
Publicado: (2013)

Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma
por: Okuno, Keisuke, et al.
Publicado: (2023)

Correction to: Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription
por: Huang, Xince, et al.
Publicado: (2022)

LOXL1-AS1 Drives The Progression Of Gastric Cancer Via Regulating miR-142-5p/PIK3CA Axis
por: Li, Ming, et al.
Publicado: (2019)

NMDAR signaling facilitates the IPO5-mediated nuclear import of CPEB3
por: Chao, Hsu-Wen, et al.
Publicado: (2012)

Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries
por: Komenkul, Kulabutr, et al.
Publicado: (2017)

Translation and cultural adaptation of IPOS (integrated palliative care outcome scale) in Estonia
por: Laissaar, Merli, et al.
Publicado: (2021)

Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling
por: Gu, Yang, et al.
Publicado: (2021)

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
por: Lin, Tingting, et al.
Publicado: (2019)

Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway
por: Zhou, Changsheng, et al.
Publicado: (2023)

UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway
por: Sun, Jingjie, et al.
Publicado: (2021)

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway
por: Bajpai, Deepti, et al.
Publicado: (2021)

How to create the next Facebook: seeing your startup through, from idea to IPO
por: Taulli, Tom
Publicado: (2012)

Do Executives' Backgrounds Matter to IPO Investors? Evidence from the Life Science Industry
por: Chok, Jay, et al.
Publicado: (2013)

Translational Science by Public Biotechnology Companies in the IPO“Class of 2000”: The Impact of Technological Maturity
por: McNamee, Laura, et al.
Publicado: (2013)

Pricing Constraint and the Complexity of IPO Timing in the Stock Market: A Dynamic Game Analysis
por: Hu, Zhiqiang, et al.
Publicado: (2020)

IPO11 mediates βcatenin nuclear import in a subset of colorectal cancers
por: Mis, Monika, et al.
Publicado: (2019)

Validation and cultural adaptation of the Integrated Palliative care Outcome Scale (IPOS) for the Portuguese population
por: Antunes, Bárbara, et al.
Publicado: (2020)

Long Non-Coding RNA LINC01410 Promoted Tumor Progression via the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer
por: Lu, Lili, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s88q42id0nnomqdjr911rg9kiv